KaiserD. G., GlennE. M., JohnsonR. H., and JohnstonR. L.: Correlation of Serum Indoxole (2,3-Bis-(p-Methoxyphenyl) Indole] Levels with Biologic Activity, J. Pharm. Exptl. Therap.156: 174–180, 1967.
2.
WagnerJ. G., GerardE. S., and KaiserD. G.: The Effect of the Dosage Form on Serum Levels of Indoxole, Clin. Pharmacol. Therap.7: 610–619, 1966.
3.
WagnerJ. G., and NelsonE.: The Kinetic Analysis of Blood Levels and Urinary Excretion in the Absorptive Phases After Single Doses of Drugs, J. Pharm. Sci.53: 1392–1403, 1964.
4.
WagnerJ. G.: Method of Estimating Relative Absorption of a Drug in a Series of Clinical Studies in Which Blood Levels Are Measured After Single and/or Multiple Doses, J. Pharm. Sci.56: 652–653, 1967.
5.
OserB. L., MelnickD., and HochbergM.: Physiological Availability of the Vitamins. Study of Methods for Determining Availability of Vitamins in Pharmaceutical Products, Ind. Eng. Chem. Anal. Chem. Educ.17: 405, 1945.
6.
SugarmanA. A., and RosenE.: Absorption Efficiency and Excretion Profile of a Prolonged Action Form of Chlorpromazine, Clin, Pharmacol. Therap.5: 561–568, 1964.
7.
NelsonE.: Physiochemical and Pharmaceutic Properties of Drugs That Influence Results of Clinical Trials, Clin. Pharmacol. Therap.3: 673–681, 1962.
